Literature DB >> 8869217

Adult Still's disease. Part II. Management, outcome, and prognostic factors.

C Masson1, X Le Loët, F Lioté, P Renou, J J Dubost, M C Boissier, L Brithmer, C Brégeon, M Audran.   

Abstract

DESIGN: a multicenter study conducted in France identified 65 cases of adult Still's disease. Follow-up exceeded one year in 52 cases.
OBJECTIVES: were as follows: 1) to describe treatments used; 2) to analyze disease course patterns; 3) to study joint alterations; 4) to determine whether any characteristics present within the first six months of onset were of prognostic significance.
RESULTS: aspirin was ineffective. Indomethacin ensured satisfactory control in eight patients. Corticosteroid therapy was required in 88% of cases. Among patients followed up for more than one year, half developed radiologic joint alterations; 23% had monocyclic systemic disease, 38.5% had polycyclic systemic disease and 38.5% had chronic articular disease. More than half of the patients (58%) had more than one systemic flare. Polyarthritis at onset and involvement of the proximal limb joints were significantly predictive of chronic articular disease, whereas isolated arthralgia was predictive of monocyclic or polycyclic systemic disease. Oligoarthritis was not predictive of the outcome.
CONCLUSION: the knowledge that polyarthritis or proximal limb joint involvement within six months of onset is predictive of chronic joint disease may have important therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8869217

Source DB:  PubMed          Journal:  Rev Rhum Engl Ed        ISSN: 1169-8446


  9 in total

1.  Sore throat and hyperferritinaemia.

Authors:  J Kelly; P Chowienczyk; T Gibson
Journal:  J R Soc Med       Date:  2001-08       Impact factor: 5.344

2.  Tumour necrosis factor alpha blocking agents in refractory adult Still's disease: an observational study of 20 cases.

Authors:  B Fautrel; J Sibilia; X Mariette; B Combe
Journal:  Ann Rheum Dis       Date:  2004-06-07       Impact factor: 19.103

3.  A long story begun with a simple sore throat.

Authors:  Giuseppina Pisano; Paola Bonara; Paolo Rietti; Lorena Airaghi; Luigi Sinigaglia; Giovanni Boccoli; Larry Burdick; Marta del Medico; Edoardo Pulixi; Fabio Silini; Alessandra Gandolfi; Silvia Fargion
Journal:  Intern Emerg Med       Date:  2010-07-22       Impact factor: 3.397

Review 4.  Diagnosis and management of adult onset Still's disease.

Authors:  P Efthimiou; P K Paik; L Bielory
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

5.  A case of adult onset Still's disease with systemic inflammatory response syndrome complicated by fatal status epilepticus.

Authors:  Young Hoon Hong; Choong Ki Lee
Journal:  Rheumatol Int       Date:  2008-02-29       Impact factor: 2.631

Review 6.  Adult-onset Still's disease: pathogenesis, clinical manifestations and therapeutic advances.

Authors:  Apostolos Kontzias; Petros Efthimiou
Journal:  Drugs       Date:  2008       Impact factor: 9.546

7.  Adult Onset Still's Disease Associated with Mycoplasma pneumoniae Infection and Hemophagocytic Lymphohistiocytosis.

Authors:  Abhishek Agnihotri; Allison Ruff; Lauren Gotterer; Addie Walker; Amy H McKenney; Andrei Brateanu
Journal:  Case Rep Med       Date:  2016-10-26

Review 8.  Mechanisms, biomarkers and targets for adult-onset Still's disease.

Authors:  Eugen Feist; Stéphane Mitrovic; Bruno Fautrel
Journal:  Nat Rev Rheumatol       Date:  2018-10       Impact factor: 20.543

9.  Adult-Onset Still's Disease: From Pathophysiology to Targeted Therapies.

Authors:  Clio P Mavragani; Evangelos G Spyridakis; Michael Koutsilieris
Journal:  Int J Inflam       Date:  2012-06-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.